Key facts
- This page summarizes Christopher R. Sansone's Form 4 filing for InfuSystem Holdings, Inc (INFU).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 22 Feb 2022, 12:06.
Christopher R. Sansone - 17 Feb 2022 Form 4 Insider Report for InfuSystem Holdings, Inc (INFU)
- Reporting relationship
- Director
- Issuer ticker
- INFU
- Reported as of
- 17 Feb 2022
- Net transaction value
- +$49,500
- SEC form
- 4
- Accepted by SEC
- 22 Feb 2022, 12:06:50 UTC
- Prior SEC filing
- 24 Nov 2021
- Next SEC filing
- 17 May 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Kevin Whitman, Attorney-in-Fact for Christopher R. Sansone
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Christopher R. Sansone filed Form 4 for InfuSystem Holdings, Inc (INFU) on 22 Feb 2022.
Change
- Previous filing in this sequence was filed on 24 Nov 2021.
- Current net transaction value: +$49,500.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
INFU
transaction
Common Stock
Options Exercise
- Transaction value
- $49,500
- Shares
- +25,000
- Change %
- Price
- $1.98*
- Shares after
- 25,000
- Date
- 17 Feb 2022
- Ownership
- Direct
INFU
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 1,464,916
- Date
- 17 Feb 2022
- Ownership
- See
- Footnotes
- F1
INFU
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 228,118
- Date
- 17 Feb 2022
- Ownership
- See
- Footnotes
- F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
INFU
transaction
Derivative
Stock Option (right to buy)
Options Exercise
- Transaction value
- $0
- Shares
- -25,000
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 17 Feb 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 25,000
- Exercise price
- $1.98
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
The reported securities are directly owned by Sansone Partners, L.P., a Delaware limited partnership. The Reporting Person is the managing member of (i) the general partner of this limited partnership and (ii) the investment manager of this limited partnership and, as such, may be deemed to indirectly beneficially own the shares held by this limited partnership. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
Footnote F2
The reported securities are directly owned by Sansone Partners (QP), L.P., a Delaware limited partnership. The Reporting Person is the managing member of (i) the general partner of this limited partnership and (ii) the investment manager of this limited partnership and, as such, may be deemed to indirectly beneficially own the shares held by this limited partnership. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
Footnote F3
The options, representing the right to purchase a total of 25,000 shares of InfuSystem Holdings, Inc. common stock, vested in twelve monthly installments beginning October 7, 2017.